TTY Biopharm Co Ltd Free Cash Flow Generation Index
TTY Biopharm Co Ltd free cash flow generation index. TTY Biopharm Co Ltd (4105) has a Free Cash Flow Generation Index of 0.80x as of March 2026. Free cash flow of NT$525.88 Million represents 1% of operating cash flow (NT$654.16 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of TTY Biopharm Co Ltd (2017–2025)
Free cash flow generation index of TTY Biopharm Co Ltd from 2017 to 2025. Historical FCF Generation Index trend for TTY Biopharm Co Ltd across 9 annual periods. See 4105 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
TTY Biopharm Co Ltd Free Cash Flow Generation Index by Year (2017–2025)
TTY Biopharm Co Ltd free cash flow generation index by year from 2017 to 2025. Year-by-year Free Cash Flow Generation Index for TTY Biopharm Co Ltd. For the full cash flow conversion analysis, see how efficiently does TTY Biopharm Co Ltd generate cash.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | NT$1.61 Billion | NT$1.76 Billion | NT$150.83 Million | ▲ +1.5% |
| 2024 | 0.90x | NT$1.22 Billion | NT$1.35 Billion | NT$134.29 Million | ▼ -0.9% |
| 2023 | 0.91x | NT$985.73 Million | NT$1.09 Billion | NT$99.58 Million | ▲ +2.0% |
| 2022 | 0.89x | NT$1.10 Billion | NT$1.24 Billion | NT$135.50 Million | ▼ -5.4% |
| 2021 | 0.94x | NT$1.18 Billion | NT$1.26 Billion | NT$74.15 Million | ▲ +43.8% |
| 2020 | 0.65x | NT$344.49 Million | NT$526.35 Million | NT$181.86 Million | ▼ -30.5% |
| 2019 | 0.94x | NT$1.14 Billion | NT$1.21 Billion | NT$69.86 Million | ▲ +2.4% |
| 2018 | 0.92x | NT$987.49 Million | NT$1.07 Billion | NT$74.09 Million | ▲ +1.9% |
| 2017 | 0.90x | NT$899.03 Million | NT$996.52 Million | NT$96.79 Million | — |